nyjobsource.com/astrazeneca.html

AstraZeneca is one of the world's leading pharmaceutical companies, with a broad ... In 1992, in the US, ICI Americas Inc. changed its name to Zeneca Inc. and ...

www.businesswire.com/news/home/20180516005544/en/Emulate-AstraZeneca-Form-Strategic-Agreement-Work-Side-by-Side

May 16, 2018 ... Emulate, Inc. and AstraZeneca formed a strategic agreement to use Organs-on- Chips Technology to improve prediction of human ...

www.biopharmadive.com/news/astrazeneca-sells-us-rights-to-4-non-core-drugs/513885

Jan 2, 2018 ... Continuing efforts to focus R&D, AstraZeneca plc closed out the year with yet another non-core asset sale that hands ANI Pharmaceuticals Inc.

www.avara.com/blog/avara-acquires-astrazeneca-uk-manufacturing-facility

Sep 6, 2016 ... Norwalk, CT, September 6, 2016 - Avara Pharmaceutical Services, Inc. (“Avara”) today announced that they have entered into an agreement ...

www.marketwatch.com/story/astrazeneca-names-dubious-doc-to-head-cancer-rd-2019-01-07

Jan 7, 2019 ... AstraZeneca PLC has appointed José Baselga, a prominent but controversial cancer doctor, to lead ... based Ironwood Pharmaceuticals Inc.

www.marketwatch.com/investing/stock/azn

AstraZeneca PLC ADR stock price, stock quotes and financial overviews from ... AstraZeneca profit falls, sees sales growth in '19 ..... Biogen Inc. 2.51%, $65.48B.

www.thetimes.co.uk/article/astra-zeneca-mulls-over-choice-of-successor-to-pascal-soriot-55k5bw56c

Nov 18, 2018 ... The FTSE 100 drugs giant Astra Zeneca has begun succession planning for Pascal Soriot, its chief executive of six years, after pressure from ...

www.jto.org/article/S1556-0864(18)30415-5/pdf

Honoraria Astellas Pharma Inc., Ono Pharmaceutical Co.,. Ltd. for Consulting or advisor role. J.E. Gray: Advisor to. Astra Zeneca. T. Hovey: Working as a ...

globenewswire.com/news-release/2018/12/13/1666887/0/en/Guardant-Health-Partners-with-AstraZeneca-to-Develop-Blood-Based-Companion-Diagnostic-Tests-for-Tagrisso-and-Imfinzi.html

Dec 13, 2018 ... December 13, 2018 12:15 ET | Source: Guardant Health, Inc. ... for plasma-based tumor mutational burden analysis in AstraZeneca trial.